Vault-13

Stonepine Capital Management, LLC

Bend, OR · CIK 1440771 · 13F filing filed 2026-08-17

SEC-registered investment adviser since 2026 · limited liability company

$131.4m reported value +15.5% vs Q1 2026
72positions
55.3%in top 10
19 new 23 added 25 reduced 13 sold out vs Q1 2026

Options: 15 call positions ($45.9m notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 VERASTEM INC COM NEW VSTM VSTM 3,349,627 $12.8m9.74% 9.74% AddedShares held: Q3 2025 2.7m, Q4 2025 2.7m, Q1 2026 3.3m, Q2 2026 3.3m +47.3k +47,327 1.4%
2 EVOLUS INC COM EOLS EOLS 1,590,162 $11.0m8.40% 8.40% ReducedShares held: Q3 2025 1.5m, Q4 2025 1.6m, Q1 2026 1.8m, Q2 2026 1.6m -168.9k -168,929 -9.6%
3 TENAX THERAPEUTICS INC COM NEW TENX TENX 660,000 $9.6m7.31% 7.31% ReducedShares held: Q3 2025 0, Q4 2025 11.9k, Q1 2026 975.2k, Q2 2026 660.0k -315.2k -315,200 -32.3%
4 NEKTAR THERAPEUTICS COM NEW NKTR NKTR 120,654 $8.4m6.41% 6.41% AddedShares held: Q3 2025 85.0k, Q4 2025 85.0k, Q1 2026 85.0k, Q2 2026 120.7k +35.7k +35,654 42.0%
5 ADMA BIOLOGICS INC COM ADMA ADMA 740,000 $6.2m4.72% 4.72% UnchangedShares held: Q3 2025 739.0k, Q4 2025 740.0k, Q1 2026 740.0k, Q2 2026 740.0k
6 CAMP4 THERAPEUTICS CORP COM CAMP CAMP 1,389,622 $6.1m4.62% 4.62% UnchangedShares held: Q3 2025 0, Q4 2025 228.9k, Q1 2026 1.4m, Q2 2026 1.4m
7 ELOXX PHARMACEUTICALS INC COM NEW ELOX ELOX 397,160 $5.5m4.20% 4.20% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 397.2k
8 KAZIA THERAPEUTICS LTD SPONSORED ADS KZIA KZIA 345,179 $4.9m3.70% 3.70% UnchangedShares held: Q3 2025 0, Q4 2025 460.4k, Q1 2026 345.2k, Q2 2026 345.2k
9 INDIVIOR PHARMACEUTICALS INC COM INDV INDV 100,000 $4.1m3.12% 3.12% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 100.0k
10 CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP CRBP 425,000 $4.0m3.03% 3.03% AddedShares held: Q3 2025 0, Q4 2025 389.9k, Q1 2026 383.5k, Q2 2026 425.0k +41.5k +41,538 10.8%
11 SATELLOS BIOSCIENCE INC COM MSLE MSLE 491,624 $3.7m2.83% 2.83% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 100.0k, Q2 2026 491.6k +391.6k +391,624 391.6%
12 ZEVRA THERAPEUTICS INC COM NEW ZVRA ZVRA 258,701 $3.7m2.82% 2.82% ReducedShares held: Q3 2025 810.0k, Q4 2025 569.1k, Q1 2026 480.0k, Q2 2026 258.7k -221.3k -221,299 -46.1%
13 ABEONA THERAPEUTICS INC COM NEW ABEO ABEO 557,284 $3.4m2.62% 2.62% ReducedShares held: Q3 2025 451.0k, Q4 2025 709.5k, Q1 2026 746.6k, Q2 2026 557.3k -189.3k -189,303 -25.4%
14 EDESA BIOTECH INC COM NEW EDSA EDSA 456,439 $3.2m2.43% 2.43% AddedShares held: Q3 2025 687.5k, Q4 2025 687.5k, Q1 2026 30.0k, Q2 2026 456.4k +426.4k +426,439 1421.5%
15 CABALETTA BIO INC COM CABA CABA 917,100 $2.9m2.17% 2.17% AddedShares held: Q3 2025 0, Q4 2025 171.1k, Q1 2026 50.0k, Q2 2026 917.1k +867.1k +867,100 1734.2%
16 AN2 THERAPEUTICS INC COM ANTX ANTX 551,692 $2.7m2.03% 2.03% ReducedShares held: Q3 2025 563.9k, Q4 2025 627.7k, Q1 2026 713.8k, Q2 2026 551.7k -162.2k -162,153 -22.7%
17 XILIO THERAPEUTICS INC COM XLO XLO 225,994 $2.2m1.65% 1.65% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 64.2k, Q2 2026 226.0k +161.8k +161,832 252.2%
18 ADICET BIO INC COM NEW ACET ACET 245,518 $2.1m1.61% 1.61% AddedShares held: Q3 2025 0, Q4 2025 220.0k, Q1 2026 222.0k, Q2 2026 245.5k +23.6k +23,563 10.6%
19 TELA BIO INC COM TELA TELA 2,662,427 $2.0m1.52% 1.52% AddedShares held: Q3 2025 2.2m, Q4 2025 2.4m, Q1 2026 2.6m, Q2 2026 2.7m +45.2k +45,175 1.7%
20 AYTU BIOPHARMA INC COM AYTU AYTU 912,921 $2.0m1.49% 1.49% AddedShares held: Q3 2025 891.9k, Q4 2025 813.7k, Q1 2026 792.3k, Q2 2026 912.9k +120.6k +120,632 15.2%
21 CURIS INC COM COM 3,312,185 $1.7m1.32% 1.32% ReducedShares held: Q3 2025 0, Q4 2025 59.3k, Q1 2026 3.7m, Q2 2026 3.3m -414.2k -414,221 -11.1%
22 SPRUCE BIOSCIENCES INC COM NEW SPRB SPRB 28,795 $1.6m1.18% 1.18% NewShares held: Q3 2025 0, Q4 2025 19.7k, Q1 2026 0, Q2 2026 28.8k
23 OKYO PHARMA LTD SHS NEW OKYO OKYO 862,996 $1.3m0.99% 0.99% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 850.0k, Q2 2026 863.0k +13.0k +12,996 1.5%
24 PASITHEA THERAPEUTICS CORP COM NEW KTTA KTTA 2,201,468 $1.1m0.86% 0.86% AddedShares held: Q3 2025 0, Q4 2025 275.1k, Q1 2026 831.3k, Q2 2026 2.2m +1.4m +1,370,167 164.8%
25 SOL-GEL TECHNOLOGIES LTD SHS NEW SLGL SLGL 14,469 $1.1m0.82% 0.82% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 27.8k, Q2 2026 14.5k -13.3k -13,309 -47.9%
26 PULMONX CORP COM LUNG LUNG 815,436 $1.1m0.81% 0.81% AddedShares held: Q3 2025 670.0k, Q4 2025 486.4k, Q1 2026 768.3k, Q2 2026 815.4k +47.1k +47,148 6.1%
27 X4 PHARMACEUTICALS INC COM NEW XFOR XFOR 224,989 $1.1m0.80% 0.80% ReducedShares held: Q3 2025 1.1m, Q4 2025 593.6k, Q1 2026 335.3k, Q2 2026 225.0k -110.3k -110,320 -32.9%
28 IN8BIO INC COM NEW INAB INAB 695,287 $980.4k0.75% 0.75% AddedShares held: Q3 2025 159.4k, Q4 2025 164.9k, Q1 2026 663.4k, Q2 2026 695.3k +31.9k +31,875 4.8%
29 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 50,000 $973.5k0.74% 0.74% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 50.0k
30 QUOIN PHARMACEUTICALS LTD SPONSORED ADS QNRX QNRX 199,486 $965.5k0.74% 0.74% AddedShares held: Q3 2025 0, Q4 2025 78.2k, Q1 2026 53.5k, Q2 2026 199.5k +146.0k +146,026 273.1%
31 MAXCYTE INC COM MXCT MXCT 751,606 $924.5k0.70% 0.70% ReducedShares held: Q3 2025 459.0k, Q4 2025 469.0k, Q1 2026 1.0m, Q2 2026 751.6k -253.1k -253,067 -25.2%
32 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 85,010 $922.4k0.70% 0.70% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 50.0k, Q2 2026 85.0k +35.0k +35,000 70.0%
33 AZITRA INC COM NEW AZTR AZTR 5,285,476 $886.9k0.68% 0.68% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.3m
34 CONNECT BIOPHARMA HLDGS LTD SHS CNTB CNTB 364,254 $866.9k0.66% 0.66% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 310.0k, Q2 2026 364.3k +54.3k +54,254 17.5%
35 CYBIN INC COM NEW COM NEW 129,280 $854.5k0.65% 0.65% ReducedShares held: Q3 2025 0, Q4 2025 339.9k, Q1 2026 134.1k, Q2 2026 129.3k -4.8k -4,780 -3.6%
36 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 25,000 $834.8k0.64% 0.64% NewShares held: Q3 2025 20.0k, Q4 2025 0, Q1 2026 0, Q2 2026 25.0k
37 INHIBIKASE THERAPEUTICS INC COM NEW IKT IKT 396,179 $804.2k0.61% 0.61% ReducedShares held: Q3 2025 735.0k, Q4 2025 2.3m, Q1 2026 957.2k, Q2 2026 396.2k -561.0k -561,023 -58.6%
38 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 161,583 $783.7k0.60% 0.60% ReducedShares held: Q3 2025 453.8k, Q4 2025 463.7k, Q1 2026 269.1k, Q2 2026 161.6k -107.5k -107,517 -40.0%
39 CYTOMX THERAPEUTICS INC COM CTMX CTMX 205,000 $768.8k0.59% 0.59% AddedShares held: Q3 2025 125.0k, Q4 2025 0, Q1 2026 200.0k, Q2 2026 205.0k +5.0k +5,000 2.5%
40 NUVECTIS PHARMA INC COM NVCT NVCT 40,000 $735.6k0.56% 0.56% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 40.0k
41 CRESCENT BIOPHARMA INC. COM CBIO CBIO 40,000 $720.0k0.55% 0.55% ReducedShares held: Q3 2025 0, Q4 2025 87.7k, Q1 2026 85.0k, Q2 2026 40.0k -45.0k -45,000 -52.9%
42 PMV PHARMACEUTICALS INC COM PMVP PMVP 536,086 $718.4k0.55% 0.55% ReducedShares held: Q3 2025 1.4m, Q4 2025 1.2m, Q1 2026 708.1k, Q2 2026 536.1k -172.0k -172,016 -24.3%
43 ORUKA THERAPEUTICS INC COM ORKA ORKA 7,500 $713.8k0.54% 0.54% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 7.5k
44 RADIOPHARM THERANOSTICS LTD SPONSORED ADS RADX RADX 51,000,000 $670.5k0.51% 0.51% UnchangedShares held: Q3 2025 0, Q4 2025 51.0m, Q1 2026 51.0m, Q2 2026 51.0m
45 ONKURE THERAPEUTICS INC COM CL A OKUR OKUR 130,684 $595.9k0.45% 0.45% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 132.6k, Q2 2026 130.7k -1.9k -1,894 -1.4%
46 NERVGEN PHARMA CORP COM NGEN NGEN 271,678 $559.7k0.43% 0.43% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 271.7k
47 CALCIMEDICA INC COM NEW COM NEW 622,432 $544.9k0.41% 0.41% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 622.4k
48 ARVINAS INC COM ARVN ARVN 60,000 $498.6k0.38% 0.38% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 27.5k, Q2 2026 60.0k +32.5k +32,500 118.2%
49 BIOAGE LABS INC COM BIOA BIOA 20,000 $490.2k0.37% 0.37% ReducedShares held: Q3 2025 188.6k, Q4 2025 45.0k, Q1 2026 50.0k, Q2 2026 20.0k -30.0k -30,000 -60.0%
50 OPUS GENETICS INC COM IRD IRD 100,718 $414.0k0.32% 0.32% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 68.7k, Q2 2026 100.7k +32.0k +32,030 46.6%
51 QT IMAGING HLDGS INC COM QTI QTI 100,000 $407.0k0.31% 0.31% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 100.0k
52 BOUNDLESS BIO INC COM BOLD BOLD 154,595 $386.5k0.29% 0.29% ReducedShares held: Q3 2025 413.5k, Q4 2025 710.1k, Q1 2026 597.7k, Q2 2026 154.6k -443.1k -443,087 -74.1%
53 SINTX TECHNOLOGIES INC COM NEW SINT SINT 209,205 $332.5k0.25% 0.25% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 209.2k
54 CELLECTAR BIOSCIENCES INC COM NEW CLRB CLRB 104,550 $290.6k0.22% 0.22% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 104.5k
55 EUPRAXIA PHARMACEUTICALS INC COM EPRX EPRX 43,491 $287.5k0.22% 0.22% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 43.5k
56 SAB BIOTHERAPEUTICS INC COM NEW SABS SABS 73,271 $285.8k0.22% 0.22% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 50.0k, Q2 2026 73.3k +23.3k +23,271 46.5%
57 ADLAI NORTYE LTD SPONSORED ADS ANL ANL 24,257 $279.0k0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 24.3k
58 SENSEONICS HLDGS INC COM SENS SENS 48,680 $276.5k0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 48.7k
59 PLIANT THERAPEUTICS INC COM PLRX PLRX 230,538 $262.8k0.20% 0.20% AddedShares held: Q3 2025 289.2k, Q4 2025 230.1k, Q1 2026 224.7k, Q2 2026 230.5k +5.9k +5,888 2.6%
60 CODEXIS INC COM CDXS CDXS 109,662 $247.8k0.19% 0.19% ReducedShares held: Q3 2025 88.3k, Q4 2025 256.1k, Q1 2026 418.0k, Q2 2026 109.7k -308.3k -308,332 -73.8%
61 PRECISION OPTICS CORP INC MA COM NEW POCI POCI 46,390 $236.6k0.18% 0.18% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 100.0k, Q2 2026 46.4k -53.6k -53,610 -53.6%
62 UPSTREAM BIO INC COM UPB UPB 33,432 $231.3k0.18% 0.18% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 35.0k, Q2 2026 33.4k -1.6k -1,568 -4.5%
63 REIN THERAPEUTICS INC COM NEW RNTX RNTX 218,038 $226.8k0.17% 0.17% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 218.0k
64 HERON THERAPEUTICS INC COM HRTX HRTX 490,787 $209.5k0.16% 0.16% ReducedShares held: Q3 2025 850.1k, Q4 2025 1.2m, Q1 2026 1.4m, Q2 2026 490.8k -911.4k -911,404 -65.0%
65 CNS PHARMACEUTICALS INC COM CNSP CNSP 41,573 $198.7k0.15% 0.15% ReducedShares held: Q3 2025 0, Q4 2025 48.8k, Q1 2026 61.0k, Q2 2026 41.6k -19.4k -19,427 -31.9%
66 HUMACYTE INC COM HUMA HUMA 231,299 $180.5k0.14% 0.14% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 231.3k
67 KALARIS THERAPEUTICS INC COM KLRS KLRS 30,122 $122.6k0.09% 0.09% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 20.4k, Q2 2026 30.1k +9.7k +9,722 47.7%
68 PROCESSA PHARMACEUTICALS INC COM SHS PCSA PCSA 55,000 $105.6k0.08% 0.08% UnchangedShares held: Q3 2025 0, Q4 2025 12.3k, Q1 2026 55.0k, Q2 2026 55.0k
69 BIOATLA INC COM NEW BCAB BCAB 16,432 $68.0k0.05% 0.05% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 16.4k
70 COMPUGEN LTD ORD CGEN CGEN 31,387 $67.2k0.05% 0.05% ReducedShares held: Q3 2025 0, Q4 2025 305.4k, Q1 2026 104.3k, Q2 2026 31.4k -72.9k -72,913 -69.9%
71 OVID THERAPEUTICS INC COM OVID OVID 21,300 $57.3k0.04% 0.04% ReducedShares held: Q3 2025 0, Q4 2025 102.4k, Q1 2026 40.0k, Q2 2026 21.3k -18.7k -18,700 -46.8%
72 EVAXION AS SPONSORED ADS EVAX EVAX 17,562 $54.4k0.04% 0.04% ReducedShares held: Q3 2025 0, Q4 2025 20.0k, Q1 2026 19.7k, Q2 2026 17.6k -2.2k -2,151 -10.9%

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
XOMA ROYALTY CORPORATION XOMA XOMA 69,500 $2.2m69.5k shares
SURROZEN INC SRZN SRZN 33,005 $961.4k33.0k shares
VERRICA PHARMACEUTICALS INC VRCA VRCA 99,735 $527.6k99.7k shares
CANDEL THERAPEUTICS INC CADL CADL 102,500 $502.2k102.5k shares
ESTABLISHMENT LABS HLDGS INC ESTA ESTA 6,000 $340.7k6.0k shares
JANUX THERAPEUTICS INC JANX JANX 20,000 $278.0k20.0k shares
OMNIAB INC OABI OABI 164,045 $257.6k164.0k shares
XERIS BIOPHARMA HOLDINGS INC XERS XERS 40,030 $232.2k40.0k shares
NEUMORA THERAPEUTICS INC. NMRA NMRA 100,000 $195.0k100.0k shares
SI-BONE INC SIBN SIBN 14,964 $189.0k15.0k shares
ELEDON PHARMACEUTICALS INC ELDN ELDN 35,000 $107.8k35.0k shares
MANNKIND CORP MNKD MNKD 16,300 $39.9k16.3k shares
BIOATLA INC BCAB BCAB 65,387 $10.5k65.4k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
ADMA BIOLOGICS INC ADMA · Call ADMACall 650,000 $8.0m650.0k shares Reduced
INSMED INC INSM · Call INSMCall 40,000 $5.6m40.0k shares New
ULTRAGENYX PHARMACEUTICAL IN RARE · Call RARECall 200,000 $5.5m200.0k shares New
MEDTRONIC PLC MDT · Call MDTCall 50,000 $4.4m50.0k shares New
ABBOTT LABS ABT · Call ABTCall 40,000 $3.8m40.0k shares New
BOSTON SCIENTIFIC CORP BSX · Call BSXCall 50,000 $3.2m50.0k shares New
EVOLUS INC EOLS · Call EOLSCall 420,000 $3.1m420.0k shares Unchanged
BIOMARIN PHARMACEUTICAL INC BMRN · Call BMRNCall 50,000 $3.1m50.0k shares New
XERIS BIOPHARMA HOLDINGS INC XERS · Call XERSCall 280,000 $2.1m280.0k shares Unchanged
SI-BONE INC SIBN · Call SIBNCall 100,000 $1.5m100.0k shares Unchanged
HERON THERAPEUTICS INC HRTX · Call HRTXCall 1,000,000 $1.5m1.0m shares Unchanged
NEUMORA THERAPEUTICS INC. NMRA · Call NMRACall 500,000 $1.2m500.0k shares Unchanged
ARDELYX INC ARDX · Call ARDXCall 150,000 $1.1m150.0k shares Unchanged
DELCATH SYS INC DCTH · Call DCTHCall 100,000 $1.0m100.0k shares Unchanged
MANNKIND CORP MNKD · Call MNKDCall 250,000 $750.0k250.0k shares Reduced

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
QUOIN PHARMACEUTICALS LTD QNRX · 13G · filed 2026-05-15 QNRX 10.0% -0.6 pts 13G 2026-05-15
AEON BIOPHARMA INC AEON · 13G · filed 2026-07-21 AEON 9.9%≈ $3.9m new 13G 2026-07-21
AZITRA INC 13G · filed 2026-06-22 9.9% new 13G 2026-06-22
ELOXX PHARMACEUTICALS INC ELOX · 13G · filed 2026-06-16 ELOX 9.9%≈ $5.6m new 13G 2026-06-16
SINTX TECHNOLOGIES INC SINT · 13G · filed 2026-06-09 SINT 9.9%≈ $1.2m new 13G 2026-06-09
CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-05-15 CNSP 9.9%≈ $760.7k +2.0 pts 13G 2026-05-15
CELLECTAR BIOSCIENCES INC CLRB · 13G · filed 2026-05-11 CLRB 9.9%≈ $2.4m new 13G 2026-05-11
CURIS INC 13G · filed 2026-03-27 9.9%≈ $2.1m new 13G 2026-03-27
IN8BIO INC INAB · 13G · filed 2025-12-22 INAB 9.9%≈ $1.4m new 13G 2025-12-22
AYTU BIOPHARMA INC AYTU · 13G · filed 2025-08-13 AYTU 9.9%≈ $1.9m 13G 2025-08-13
OPTINOSE INC OPTN · 13G · filed 2025-05-14 OPTN 7.8% +1.9 pts 13G 2025-05-14
FEMASYS INC FEMY · 13G · filed 2026-08-31 FEMY 7.2%≈ $2.6m new 13G 2026-08-31
EDESA BIOTECH INC EDSA · 13G · filed 2026-08-26 EDSA 6.9%≈ $5.9m +6.6 pts 13G 2026-08-26
CALCIMEDICA INC 13G · filed 2026-08-25 6.0%≈ $2.2m +1.4 pts 13G 2026-08-25
TELA BIO INC TELA · 13G · filed 2025-02-13 TELA 6.0%≈ $1.8m 13G 2025-02-13
PASITHEA THERAPEUTICS CORP KTTA · 13G · filed 2026-06-23 KTTA 5.8%≈ $1.0m new 13G 2026-06-23